MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
488.58%
Quick Ratio
439.98%
Cash Ratio
249.18%
Debt to Asset Ratio
84.83%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Operating lease right-of-use ass...
Accounts receivable, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Liabilities related to future ro...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
171,414
130,925
86,124
123,825
Marketable securities - available-for-sale debt securities
30,216
98,509
281,289
330,454
Restricted cash
1,496
1,493
1,498
1,507
Accounts receivable, net
44,392
27,663
32,604
26,644
Inventories, net
33,431
33,233
27,723
23,943
Prepaid expenses and other current assets
55,142
77,012
85,339
67,877
Total current assets
336,091
368,835
514,577
574,250
Property and equipment, net
60,523
61,908
66,851
66,467
Intangible assets, net
18,532
18,976
20,283
12,933
Prepaid expenses and other non-current assets
165
194
191
5,258
Operating lease right-of-use assets, net
74,111
72,563
56,625
58,619
Long-term deposits
1,016
1,014
1,031
1,052
Deferred tax asset
2,788
3,575
2,389
2,402
Total assets
493,226
527,065
661,947
720,981
Accounts payable
1,366
1,872
10,967
5,408
Compensation and benefits
19,663
18,718
-
-
Rebates, chargebacks and returns
9,193
6,730
-
-
Research and development costs
6,887
5,506
-
-
Professional fees
6,324
5,655
-
-
Manufacturing accruals
4,204
7,544
-
-
Other liabilities
2,464
2,613
-
-
Accrued expenses and other liabilities
48,735
46,766
52,264
51,366
Deferred revenue
-
-
7,612
2,100
Operating lease liabilities, current
5,789
3,061
4,828
3,277
Liabilities related to future royalties and milestones, net - current
12,900
11,900
7,400
6,000
Total current liabilities
68,790
63,599
83,071
68,151
Operating lease liabilities, non-current
77,723
76,895
61,007
61,258
Liabilities related to future royalties and milestones, net - non-current
271,400
277,268
251,945
244,631
Other long-term payables
474
477
472
477
Total liabilities
418,387
418,239
396,495
374,517
Ordinary and deferred shares, value-Ordinary Shares
12
12
12
12
Ordinary and deferred shares, value-Deferred Shares
0
0
0
0
Ordinary and deferred shares, value-Deferred Class BShares
118
118
118
118
Ordinary and deferred shares, value-Deferred Class CShares
0
0
0
0
Additional paid-in capital
1,578,271
1,573,673
1,566,662
1,562,774
Accumulated other comprehensive loss
-6,101
-6,627
-4,920
862
Accumulated deficit
-1,497,461
-1,458,350
-1,296,420
-1,217,302
Total shareholders equity
74,839
108,826
265,452
346,464
Total liabilities and shareholders equity
493,226
527,065
661,947
720,981
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$171,414K
(38.43%↑ Y/Y)
Prepaid expenses and
other current assets
$55,142K
(-18.76%↓ Y/Y)
Accounts receivable, net
$44,392K
(66.61%↑ Y/Y)
Inventories, net
$33,431K
(39.63%↑ Y/Y)
Marketable securities -
available-for-sale debt securities
$30,216K
(-90.86%↓ Y/Y)
Restricted cash
$1,496K
(-0.73%↓ Y/Y)
Total current assets
$336,091K
(-41.47%↓ Y/Y)
Operating lease
right-of-use assets, net
$74,111K
(26.43%↑ Y/Y)
Property and equipment,
net
$60,523K
(-8.94%↓ Y/Y)
Intangible assets, net
$18,532K
(43.29%↑ Y/Y)
Deferred tax asset
$2,788K
(16.07%↑ Y/Y)
Long-term deposits
$1,016K
(-3.42%↓ Y/Y)
Prepaid expenses and
other non-current...
$165K
(-96.86%↓ Y/Y)
Total assets
$493,226K
(-31.59%↓ Y/Y)
Total liabilities and
shareholders equity
$493,226K
(-31.59%↓ Y/Y)
Total liabilities
$418,387K
(11.71%↑ Y/Y)
Total shareholders
equity
$74,839K
(-78.40%↓ Y/Y)
Accumulated deficit
-$1,497,461K
(-23.01%↓ Y/Y)
Accumulated other
comprehensive loss
-$6,101K
(-807.77%↓ Y/Y)
Liabilities related to
future royalties and...
$271,400K
(10.94%↑ Y/Y)
Operating lease
liabilities, non-current
$77,723K
(26.88%↑ Y/Y)
Total current
liabilities
$68,790K
(0.94%↑ Y/Y)
Other long-term
payables
$474K
(-0.63%↓ Y/Y)
Additional paid-in capital
$1,578,271K
(0.99%↑ Y/Y)
Ordinary and deferred
shares, value-Deferred...
$118K
(0.00%↑ Y/Y)
Ordinary and deferred
shares, value-Ordinary...
$12K
(0.00%↑ Y/Y)
Accrued expenses and
other liabilities
$48,735K
(-5.12%↓ Y/Y)
Liabilities related to
future royalties and...
$12,900K
(115.00%↑ Y/Y)
Operating lease
liabilities, current
$5,789K
(76.66%↑ Y/Y)
Accounts payable
$1,366K
(-74.74%↓ Y/Y)
Compensation and benefits
$19,663K
Rebates, chargebacks and
returns
$9,193K
Research and development
costs
$6,887K
Professional fees
$6,324K
Manufacturing accruals
$4,204K
Other liabilities
$2,464K
Buy us a coffee
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)